Abstract:Uncovering the stimulus-response histories that give rise to cell fates and behaviors is an area of great interest in developmental biology, tissue engineering, and regenerative medicine. A comprehensive accounting of cell experiences that lead to the development of organs and tissues can help us to understand developmental anomalies that may underly disease. Perhaps more provocatively, such a record can also reveal clues as to how to drive cell collective decision-making processes, which may yield predictable cell-based therapies or facilitate production of tissue substitutes for transplantation or in vitro screening of prospective therapies to mitigate disease. Toward this end, various methods have been applied to molecularly trace developmental trajectories and record interaction histories of cells. Typical methods involve artificial gene circuits based on recombinases that activate a suite of fluorescent reporters or CRISPR-Cas9 genome writing technologies whose nucleic acid-based record keeping serves to chronicle cell-cell interactions or past exposure to stimuli of interests. Exciting expansions of the synthetic biology toolkit with artificial receptors that permit establishment of defined input-to-output linkages of cell decision-making processes opens the door to not only record cell-cell interactions, but to also potentiate directed manipulation of the outcomes of such interactions via regulation of carefully selected transgenes. Here, we combine CRISPR-based strategies to genetically and epigenetically manipulate cells to express components of the synthetic Notch receptor platform, a widely used artificial cell signaling module. Our approach gives rise to the ability to conditionally record interactions between human cells, where the record of engagement depends on expression of a state-specific marker of a subset of cells in a population. Further, such signal-competent interactions can be used to direct differentiation of human embryonic stem cells toward pre-selected fates based on assigned synNotch outputs. We also implemented CRISPR-based manipulation of native gene expression profiles to bias outcomes of cell engagement histories in a targeted manner. Thus, we present a useful strategy that gives rise to both state-specific recording of cell-cell interactions as well as methods to intentionally influence products of such cell-cell exchanges.

Customizable gene sensing and response without altering endogenous coding sequences

Synthetic Protein-Binding DNA Sponge As a Tool to Tune Gene Expression and Mitigate Protein Toxicity

Programming Living Sensors for Environment, Health and Biomanufacturing

Digital switching in a biosensor circuit via programmable timing of gene availability

Engineering Synthetic CopT/A-Based Genetic Biosensors for miRNA Imaging and Functional Gene Regulation

Universal DNA-Based Sensing Toolbox for Programming Cell Functions

Encoding Genetic Circuits with DNA Barcodes Paves the Way for Machine Learning-Assisted Metabolite Biosensor Response Curve Profiling in Yeast

High-resolution and programmable RNA-IN and RNA-OUT genetic circuit in living mammalian cells

Use of CRISPRoff and synthetic Notch to modulate and relay endogenous gene expression programs in engineered cells

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection

Custom-made transcriptional biosensors for metabolic engineering

Clinically-driven design of synthetic gene regulatory programs in human cells

A general strategy to engineer high-performance mammalian Whole-Cell Biosensors

Encoding Genetic Circuits with DNA Barcodes Paves the Way for High-Throughput Profiling of Dose-Response Curves of Metabolite Biosensors.

Multifunctional Systems in Synthetic Biology: Single-Stranded DNA Signaling for Precise Control of Gene Activation

Modular design of synthetic receptors for programmed gene regulation in cell therapies

A Versatile CRISPR/Cas12a-based Biosensing Platform Coupled with a Target-Protected Transcription Strategy.

Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli

Gene circuit-based sensors

A discovery platform to identify inducible synthetic circuitry from varied microbial sources